tiprankstipranks
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
Company AnnouncementsNoxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
1M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
1M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
1M ago
NOX
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
PremiumCompany Announcements
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
1M ago
NOX
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
PremiumCompany Announcements
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
1M ago
NOX
Noxopharm’s Sofra Platform Science Published in Top Immunology Journal
PremiumCompany AnnouncementsNoxopharm’s Sofra Platform Science Published in Top Immunology Journal
2M ago
NOX
Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
Premium
Company Announcements
Noxopharm Clears Key Safety Milestone as HERACLES Trial Concludes and Sofra Platform Gains Global Traction
2M ago
NOX
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
Premium
Company Announcements
Noxopharm Clears Safety Milestone as HERACLES Trial for SOF-SKN Concludes
2M ago
NOX
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
PremiumCompany Announcements
Noxopharm Rolls Over $2.6m in Convertible Notes, Flagging Potential Share Dilution
3M ago
NOX
Noxopharm Issues New Unquoted Options and Convertible Notes
PremiumCompany Announcements
Noxopharm Issues New Unquoted Options and Convertible Notes
3M ago
NOX
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
PremiumCompany Announcements
Noxopharm Redeems 2.6 Million Convertible Notes, Trimming Convertible Debt
3M ago
NOX
Noxopharm Ltd. Announces Director’s Interest Change
PremiumCompany Announcements
Noxopharm Ltd. Announces Director’s Interest Change
4M ago
NOX
Noxopharm Issues Convertible Notes to Restructure Capital
PremiumCompany AnnouncementsNoxopharm Issues Convertible Notes to Restructure Capital
4M ago
NOX
Noxopharm Ltd. Issues New Equity Securities to Bolster Growth
Premium
Company Announcements
Noxopharm Ltd. Issues New Equity Securities to Bolster Growth
4M ago
NOX
Noxopharm Advances SOF-SKN™ Clinical Trial for Autoimmune Diseases
Premium
Company Announcements
Noxopharm Advances SOF-SKN™ Clinical Trial for Autoimmune Diseases
4M ago
NOX
Noxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
PremiumCompany Announcements
Noxopharm’s AGM Resolutions Passed, Highlighting Growth Potential of Sofra Platform
5M ago
NOX
Noxopharm Unveils 2025 AGM Presentation, Showcasing Clinical and Market Advancements
PremiumCompany Announcements
Noxopharm Unveils 2025 AGM Presentation, Showcasing Clinical and Market Advancements
5M ago
NOX
Noxopharm Advances Sofra™ Platform with Promising Clinical Trials
PremiumCompany Announcements
Noxopharm Advances Sofra™ Platform with Promising Clinical Trials
5M ago
NOX
Noxopharm Advances HERACLES Trial with SOF-SKN Dosing
PremiumCompany Announcements
Noxopharm Advances HERACLES Trial with SOF-SKN Dosing
5M ago
NOX
Noxopharm and UNSW Sydney Collaborate on Inflammation Study with Government Grant
PremiumCompany AnnouncementsNoxopharm and UNSW Sydney Collaborate on Inflammation Study with Government Grant
5M ago
NOX
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN
Premium
Company Announcements
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN
5M ago
NOX
Noxopharm Advances Sofra Platform with New Collaborations and Promising Trial Results
Premium
Company Announcements
Noxopharm Advances Sofra Platform with New Collaborations and Promising Trial Results
5M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >